MUC16 and neoplasm: A prospective study by this group further examined serum levels of CA125-sTn and CA125-MGL at the time of diagnosis, during treatment, and follow-up in HGSOC patients and found that CA125-sTn is a considerable indicator of tumor load and disease relapse [27].